A Phase I Dose-Escalation Study of NMS-1116354 in Adult Patients With Advanced Solid Tumors.

Trial Profile

A Phase I Dose-Escalation Study of NMS-1116354 in Adult Patients With Advanced Solid Tumors.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 11 Sep 2012

At a glance

  • Drugs NMS 1116354 (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions; Registrational
  • Most Recent Events

    • 01 Sep 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov. (NCT01016327)
    • 01 Sep 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov. (NCT01016327)
    • 25 Mar 2010 Planned end date changed from 1 Sep 2010 to 1 Mar 2011 as reported by ClinicalTrials.gov (NCT01092052).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top